Brett Brodnax
CIK: 0001242772
Brett Brodnax's purchase track record
Brett Brodnax has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/19/2026 | LMRI | $254K | +71.3% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| LMRI | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 | View on chart |
| LMRI | ▲ Buy | Open Market | 35,000 | $254K | 5/19/2026 | View on chart |
| LMRI | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Lumexa Imaging (LMRI) Valuation Analysis Published
A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.
Lumexa Imaging (LMRI) Valuation Analysis Published. A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.